Direct isolation and RNA-seq reveal environment-dependent properties of engrafted neural stem/progenitor cells

Nature Communications

Volumn 3, Issue , 2012, Pages

  Kumamaru, Hiromi ^a   Ohkawa, Yasuyuki ^a   Saiwai, Hirokazu ^a   Yamada, Hisakata ^a   Kubota, Kensuke ^a   Kobayakawa, Kazu ^a   Akashi, Koichi ^a   Okano, Hideyuki ^b   Iwamoto, Yukihide ^a   Okada, Seiji ^a  

^a KYUSHU UNIVERSITY   (Japan)

^b KEIO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA TUBULIN; BRAIN DERIVED NEUROTROPHIC FACTOR; CASPASE 3; CASPASE 6; CASPASE 7; CASPASE 8; CD11B ANTIGEN; CD45 ANTIGEN; CILIARY NEUROTROPHIC FACTOR; GLIAL CELL LINE DERIVED NEUROTROPHIC FACTOR; GLIAL FIBRILLARY ACIDIC PROTEIN; GLYCERALDEHYDE 3 PHOSPHATE DEHYDROGENASE; INTEGRIN; INTERLEUKIN 10; INTERLEUKIN 1BETA; INTERLEUKIN 6; NERVE GROWTH FACTOR; NEUROHORMONE; OLIGODENDROCYTE TRANSCRIPTION FACTOR 2; PLATELET DERIVED GROWTH FACTOR A; PROTEIN KINASE B; PROTEIN S100B; SCATTER FACTOR; SOMATOMEDIN; SYNAPTOTAGMIN I; TRANSCRIPTION FACTOR SOX2; TRANSFORMING GROWTH FACTOR BETA1; TUMOR NECROSIS FACTOR ALPHA; UNINDEXED DRUG; VASCULOTROPIN A;

BIOTECHNOLOGY; DISEASE RESISTANCE; DISEASE TREATMENT; GENE EXPRESSION; GENETIC ENGINEERING; IMAGING METHOD; RNA;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; ASTROCYTE; CONTROLLED STUDY; FEMALE; FLOW CYTOMETRY; GENE EXPRESSION; HORMONE RELEASE; IN VITRO STUDY; MOUSE; NERVE CELL DIFFERENTIATION; NEURAL STEM CELL TRANSPLANTATION; NEUROPROTECTION; NONHUMAN; OLIGODENDROGLIA; RNA SEQUENCE; RNA SPLICING; SAFETY; SIGNAL TRANSDUCTION; SPINAL CORD INJURY;

ANIMALS; APOPTOSIS; CELL COUNT; CELL SEPARATION; CELL SURVIVAL; CELLULAR MICROENVIRONMENT; CENTRAL NERVOUS SYSTEM NEOPLASMS; FLOW CYTOMETRY; GENE EXPRESSION REGULATION; INFLAMMATION; LUMINESCENT MEASUREMENTS; MICE; MITOCHONDRIA; NEURAL STEM CELLS; NEUROPROTECTIVE AGENTS; RECOVERY OF FUNCTION; SEQUENCE ANALYSIS, RNA; SIGNAL TRANSDUCTION; SPINAL CORD; SPINAL CORD INJURIES; STEM CELL TRANSPLANTATION; TRANSCRIPTOME;

EID: 84869462797     PISSN: None     EISSN: 20411723     Source Type: Journal    
DOI: 10.1038/ncomms2132     Document Type: Article

References (47)

1. Bradbury, E. J. & McMahon, S. B. Opinion-Spinal cord repair strategies: why do they work? Nat Rev. Neurosci. 7, 644-653 (2006). (Pubitemid 44106746)
2. Beattie, M. S. Infammation and apoptosis: linked therapeutic targets in spinal cord injury. Trends Mol. Med. 10, 580-583 (2004). (Pubitemid 39573147)
3. Turet, S., Moon, L. D. F. & Gage, F. H. Terapeutic interventions afer spinal cord injury. Nat Rev. Neurosci. 7, 628-643 (2006). (Pubitemid 44106745)
4. Lindvall, O. & Kokaia, Z. Stem cells in human neurodegenerative disorders-time for clinical translation? J. Clin. Invest 120, 29-40 (2010).
5. Barnabe-Heider, F. & Frisen, J. Stem cells for spinal cord repair. Cell Stem Cell 3, 16-24 (2008).
6. Enzmann, G. U., Benton, R. L., Talbott, J. F., Cao, Q. L. & Whittemore, S. R. Functional considerations of stem cell transplantation therapy for spinal cord repair. J. Neurotraum. 23, 479-495 (2006).
7. Dobkin, B. H., Curt, A. & Guest, J. Cellular transplants in China: Observational study from the largest human experiment in chronic spinal cord injury. Neurorehabil. Neural Repair 20, 5-13 (2006). (Pubitemid 43214453)
8. Aboody, K., Capela, A., Niazi, N., Stern, J. H. & Temple, S. Translating stem cell studies to the clinic for CNS repair: current state of the art and the need for a rosetta stone. Neuron 70, 597-613 (2011).
9. Hofstetter, C. P. et al. Allodynia limits the usefulness of intraspinal neural stem cell grafs; directed diferentiation improves outcome. Nat Neurosci 8, 346-353 (2005). (Pubitemid 40300192)
10. Wang, Z., Gerstein, M. & Snyder, M. RNA-Seq: a revolutionary tool for transcriptomics. Nat Rev. Genet 10, 57-63 (2009).
11. Mortazavi, A., Williams, B. A., Mccue, K., Schaefer, L. & Wold, B. Mapping and quantifying mammalian transcriptomes by RNA-Seq. Nat Methods 5, 621-628 (2008). (Pubitemid 351911867)
12. Cloonan, N. et al. Stem cell transcriptome profling via massive-scale mRNA sequencing. Nat Methods 5, 613-619 (2008). (Pubitemid 351911866)
13. Okada, S. et al. In vivo imaging of engrafed neural stem cells: its application in evaluating the optimal timing of transplantation for spinal cord injury. FASEB J. 19, 1839-1841 (2005). (Pubitemid 41598768)
14. Mahalik, T. J., Hahn, W. E., Clayton, G. H. & Owens, G. P. Programmed cell-death in developing grafs of fetal substantia-nigra. Exp. Neurol. 129, 27-36 (1994). (Pubitemid 24344154)
15. Zawada, W. M., Kirschman, D. L., Cohen, J. J., Heidenreich, K. A. & Freed, C. R. Growth factors rescue embryonic dopamine neurons from programmed cell death. Exp. Neurol. 140, 60-67 (1996). (Pubitemid 26266594)
16. Zawada, W. M. et al. Growth factors improve immediate survival of embryonic dopamine neurons afer transplantation into rats. Brain Res. 786, 96-103 (1998). (Pubitemid 28191718)
17. Micci, M. A. & Pasricha, P. J. Neural stem cells for the treatment of disorders of the enteric nervous system: strategies and challenges. Dev. Dynam. 236, 33-43 (2007). (Pubitemid 46095077)
18. Carpentier, P. A. & Palmer, T. D. Immune infuence on adult neural stem cell regulation and function. Neuron 64, 79-92 (2009).
19. Martino, G. & Pluchino, S. The therapeutic potential of neural stem cells. Nat Rev. Neurosci 7, 395-406 (2006).
20. Kaltschmidt, B., Widera, D. & Kaltschmidt, C. Signaling via NF-kappa B in the nervous system. Biochim. Biophys. Acta 1745, 287-299 (2005). (Pubitemid 41330783)
21. Romashkova, J. A. & Makarov, S. S. NF-kappa B is a target of AKT in anti-apoptotic PDGF signalling. Nature 401, 86-90 (1999).
22. Zhou, Z. G., Peng, X. M., Insolera, R., Fink, D. J. & Mata, M. Interleukin-10 provides direct trophic support to neurons. J Neurochem 110, 1617-1627 (2009).
23. Sofroniew, M. V., Howe, C. L. & Mobley, W. C. Nerve growth factor signaling, neuroprotection, and neural repair. Annu. Rev. Neurosci. 24, 1217-1281 (2001). (Pubitemid 32695259)
24. Lee, J. P. et al. Stem cells act through multiple mechanisms to beneft mice with neurodegenerative metabolic disease. Nat Med. 13, 439-447 (2007).
25. Trapnell, C. et al. Transcript assembly and quantifcation by RNA-Seq reveals unannotated transcripts and isoform switching during cell diferentiation. Nat Biotechnol. 28, 511-U174 (2010).
26. Al-Shahrour, F. et al. BABELOMICS: a systems biology perspective in the functional annotation of genome-scale experiments. Nucleic Acids Res. 34, W472-476 (2006). (Pubitemid 44529816)
27. Rhee, S. Y., Wood, V., Dolinski, K. & Draghici, S. Use and misuse of the gene ontology annotations. Nat Rev. Genet 9, 509-515 (2008). (Pubitemid 351861540)
28. Youle, R. J. & Strasser, A. The BCL-2 protein family: opposing activities that mediate cell death. Nat Rev. Mol. Cell Biol. 9, 47-59 (2008).
29. Negrini, S., Gorgoulis, V. G. & Halazonetis, T. D. Genomic instability-an evolving hallmark of cancer. Nat Rev. Mol. Cell Biol. 11, 220-228 (2010).
30. Luo, J., Solimini, N. L. & Elledge, S. J. Principles of cancer therapy: oncogene and non-oncogene addiction. Cell 136, 823-837 (2009).
31. He, C., Zhou, F., Zuo, Z., Cheng, H. & Zhou, R. A global view of cancer-specifc transcript variants by subtractive transcriptome-wide analysis. PLoS One 4, e4732 (2009).
32. Stiles, C. D. & Rowitch, D. H. Glioma stem cells: a midterm exam. Neuron 58, 832-846 (2008). (Pubitemid 351842757)
33. Vescovi, A. L., Galli, R. & Reynolds, B. A. Brain tumour stem cells. Nat Rev. Cancer 6, 425-436 (2006).
34. Kanehisa, M., Goto, S., Furumichi, M., Tanabe, M. & Hirakawa, M. KEGG for representation and analysis of molecular networks involving diseases and drugs. Nucleic Acids Res. 38, D355-D360 (2010).
35. Michels, J., Johnson, P. W. & Packham, G. Mcl-1. Int. J. Biochem. Cell Biol. 37, 267-271 (2005). (Pubitemid 39330187)
36. Shieh, J. J., Liu, K. T., Huang, S. W., Chen, Y. J. & Hsieh, T. Y. Modifcation of alternative splicing of Mcl-1 pre-mRNA using antisense morpholino oligonucleotides induces apoptosis in basal cell carcinoma cells. J. Invest. Dermatol. 129, 2497-2506 (2009).
37. Salminen, A. & Kaarniranta, K. Insulin/IGF-1 paradox of aging: regulation via AKT/IKK/NF-kappa B signaling. Cell. Signal. 22, 573-577 (2010).
38. Mattson, M. P. & Mefert, M. K. Roles for NF-kappa B in nerve cell survival, plasticity, and disease. Cell Death Difer. 13, 852-860 (2006).
39. Shimada, M. et al. Chk1 is a histone H3 threonine 11 kinase that regulates DNA damage-induced transcriptional repression. Cell 132, 221-232 (2008). (Pubitemid 351172429)
40. Gentile, M., Latonen, L. & Laiho, M. Cell cycle arrest and apoptosis provoked by UV radiation-induced DNA damage are transcriptionally highly divergent responses. Nucleic Acids Res. 31, 4779-4790 (2003). (Pubitemid 37441841)
41. Cao, Q. L., Howard, R. M., Dennison, J. B. & Whittemore, S. R. Diferentiation of engrafed neuronal-restricted precursor cells is inhibited in the traumatically injured spinal cord. Exp. Neurol. 177, 349-359 (2002). (Pubitemid 35366125)
42. Amariglio, N. et al. Donor-derived brain tumor following neural stem cell transplantation in an ataxia telangiectasia patient. PLoS Med. 6, 221-231 (2009).
43. Jandial, R. & Snyder, E. Y A safer stem cell: on guard against cancer. Nat Med. 15, 999-1001 (2009).
44. Breunig, J. J., Haydar, T. F. & Rakic, P. Neural stem cells: historical perspective and future prospects. Neuron 70, 614-625 (2011).
45. Fleming, J. C. et al. The cellular infammatory response in human spinal cords afer injury. Brain 129, 3249-3269 (2006). (Pubitemid 44871440)
46. Brinkman, B. M. Splice variants as cancer biomarkers. Clin. Biochem. 37, 584-594 (2004). (Pubitemid 38845021)
47. Saiwai, H. et al. The LTB4-BLT1 axis mediates neutrophil infltration and secondary injury in experimental spinal cord injury. Am. J. Pathol. 176, 2352-2366 (2010).